Official websites use .gov

A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS

A lock ( 🔒 ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

Need Help

Understanding pH-dependent receptor utilization of Lassa virus

Award Number: R21AI180800
ORGANIZATION: NATIONAL INSTITUTE OF ALLERGY & INFECTIOUS DISEASES
OPDIV: NIH
AWARD CLASS: DISCRETIONARY
AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)
PERIOD OF PERFORMANCE START DATE: 05/24/2024
PERIOD OF PERFORMANCE END DATE: 03/31/2026

Group Awards By:

View Award Description

Understanding pH-dependent receptor utilization of Lassa virus - The Old-World Arenavirus Lassa (LASV) can cause severe hemorrhagic Lassa fever (LF), which is associated with significant morbidity and mortality in West Africa every year. As the most exported hemorrhagic fever, LASV also poses a significant global health risk. LF is recognized as a “Priority disease” by the World Health Organization (WHO) and the Coalition for Epidemic Preparedness Innovations (CEPI). The trimeric glycoprotein complex (GPC) is the only viral protein expressed on the virion surface and responsible for LASV cell entry. Each monomer within the trimer is composed of the non-covalently associated stable signal peptide, the receptor-binding subunit, GP1, and the fusion machinery, GP2. LASV sequentially utilizes two host receptors for cell entry, the matriglycosylated alpha-dystroglycan (matri-α-DG) at the cell surface and the lysosomal-associated membrane protein 1 (LAMP1) in the endosome during endocytosis of the virion. The receptor switch requires an acidic pH-induced conformational rearrangement of the GPC trimer, called GPC priming. Structural biology has only captured atomic snapshots: prefusion GPC in complex with matriglycan, and then individual subunits: post-fusion GP2, and a low-pH incubated GP1 truncation presumed to be in the primed state. The inherent metastability of GPC has thwarted efforts to obtain high-resolution structures of trimeric GPC in priming states and the GPC:LAMP1 complex. In this project, we will fill in these important missing structures and illuminate pH-driven changes in the GPC trimer and mechanisms for receptor switching. The proposed structural work for this program is made feasible by a novel LASV GPC construct engineered by the PI that maintains native conformation at neutral pH and is capable of priming and LAMP1 binding at acidic pH, without dissociation of the GP1 and GP2 subunits. Importantly, insights from these studies can be applied to other medically relevant, pH-dependent receptor-switching arenaviruses, such as the ubiquitous Lymphocytic choriomeningitis virus and the rare, but potentially more fatal, Lujo virus.


Issue Date FY	Funding FY	Legal Entity Name	Legal Entity Address	Legal Entity City	Legal Entity State	Legal Entity Zip Code	Legal Entity COUNTY	Legal Entity COUNTRY	Assistance Listing	Award Code	Budget Year	Action Date	Action Type	Action Amount

Issue Date FY: 2025 ( Subtotal = $221,888 )
2025	2025	LA JOLLA INSTITUTE FOR IMMUNOLOGY	9420 ATHENA CIR	LA JOLLA	CA	92037	SAN DIEGO	USA	Allergy and Infectious Diseases Research	000	2	3/11/2025	NON-COMPETING CONTINUATION	$221,888
														Subtotal = $221,888

Issue Date FY: 2024 ( Subtotal = $274,500 )
2024	2024	LA JOLLA INSTITUTE FOR IMMUNOLOGY	9420 ATHENA CIR	LA JOLLA	CA	92037	SAN DIEGO	USA	Allergy and Infectious Diseases Research	000	1	5/24/2024	NEW	$247,050
2024	2024	LA JOLLA INSTITUTE FOR IMMUNOLOGY	9420 ATHENA CIR	LA JOLLA	CA	92037	SAN DIEGO	USA	Allergy and Infectious Diseases Research	001	1	9/11/2024	NEW	$27,450
														Subtotal = $274,500

Grand Total All Awards = $496,388

Top

All Categories

About

Search

Reports

Data Submission

Award Information

Understanding pH-dependent receptor utilization of Lassa virus

Award Number: R21AI180800

ORGANIZATION: NATIONAL INSTITUTE OF ALLERGY & INFECTIOUS DISEASES

OPDIV: NIH

AWARD CLASS: DISCRETIONARY

AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)

PERIOD OF PERFORMANCE START DATE: 05/24/2024

PERIOD OF PERFORMANCE END DATE: 03/31/2026

Federal Websites

Department of Health & Human Services

HHS Operating Divisions

HHS Staff Divisions

Download A Document Viewer